Product
Influvac Tetra
2 clinical trials
4 indications
Indication
InfluenzaIndication
ApneaIndication
Obstructive Sleep ApneaIndication
COVID-19Clinical trial
A Phase 2a, Single Center, Randomized, Double-blind, Controlled Study to Evaluate the Immunogenicity and the Safety of One Dose of OVX836 Influenza Vaccine at Two Dose Levels (90 µg and 180 μg), in Comparison to Influvac TetraTM, Quadrivalent Seasonal Influenza Sub-unit Vaccine, After Intramuscular Administration in Healthy Subjects Aged 18-65 YearsStatus: Completed, Estimated PCD: 2020-09-07
Clinical trial
Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients. A Cohort StudyStatus: Recruiting, Estimated PCD: 2024-03-30